UPS is delivering the first doses of the Pfizer-BioNTech COVID-19 vaccines in the European Union today. The deliveries follow historic rollouts in North America and the Middle East, marking another breakthrough milestone in the response against the COVID-19 pandemic.
Category: UPS Press Release
Statement By Scott Price, President, UPS International
“We are pleased with the news that the European Medicines Agency has authorized the Pfizer-BioNTech vaccine. UPS Healthcare’s cold chain storage and transportation competencies are ready and on standby to assist with deliveries throughout Europe.
With our UPS Healthcare campus and freezer farms in the Netherlands and our European air hub situated nearby in Cologne, Germany, we are moving the world forward to deliver what matters most to help Europe stamp out this pandemic.”
UPS partners with McKesson to transport and deliver the Moderna COVID-19 vaccine
UPS continues its involvement with COVID-19 vaccine delivery efforts through a partnership with global pharmaceutical and medical supply distributor McKesson. Through contracts with the Centers for Disease Control and Prevention and the Assistant Secretary for Preparedness and Response to support Operation Warp Speed, McKesson is the centralized distributor for non-ultra-frozen COVID-19 vaccines and ancillary supply kits. Under its agreement with McKesson, UPS will begin delivering Moderna’s COVID-19 vaccine, which today received a U.S. Food and Drug Administration Emergency Use Authorization.
“This is a critically important initiative for UPS, and we are committed to delivering what matters for as long as it takes,” says Carol Tomé, CEO of UPS. “McKesson is a valued UPS Healthcare partner, and we will continue to leverage the strength of our network to safely and efficiently get these life-saving vaccines and supplies to their final destination.”
- Deployments began after federal mandate to distribute therapies within 24 hours of emergency use authorization.
- UPS to help transport the initial Pfizer-BioNTech COVID-19 vaccine doses to support vaccinations of healthcare workers.
UPS today announced its involvement and full support of distribution efforts for Pfizer-BioNTech’s COVID-19 vaccine as part of Operation Warp Speed. Pfizer’s and BioNTech’s vaccine, approved through a U.S. Food and Drug Administration emergency use authorization (EUA), is the first to be deployed in a months-long global race to develop safe vaccines to combat the spread of the COVID-19 virus.
“Vaccine distribution is a key part of moving our world forward by delivering what matters,” says Carol Tomé, CEO of UPS. “We have dedicated and hardworking people around the world who have been trained to store, handle, transport and deliver vaccines. We’re pleased to support our healthcare partners with smart, efficient logistics for these vaccines that will protect communities and save lives.”
UPS today announced the appointment of DuPont Chief Human Resources Officer Darrell Ford to the position of UPS Chief Human Resources Officer. Charlene Thomas, UPS’s current Chief Human Resources Officer, will assume the role of Chief Diversity, Equity and Inclusion Officer, a new position on the company’s Executive Leadership Team. Both appointments are effective January 1, 2021.
“Darrell is a proven leader with a track record of excellence in H.R. strategies, systems and processes that are critical to a company’s success,” said UPS Chief Executive Officer Carol Tomé. “As we continue to transform the role of H.R. and how it supports our business, Darrell’s expertise and experience will advance our efforts to optimize talent, and drive a global culture focused on purpose and service excellence.”
Ford will be responsible for developing and executing UPS’s global human resources strategy to support the company’s business plan and strategic direction. In addition to advancing UPS’s culture, Darrell’s areas of focus will include succession planning, talent acquisition and management, training and development, performance management and compensation.